Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galapagos NV (NASDAQ:GLPG)

85.17
Delayed Data
As of 3:59pm ET
 -0.67 / -0.78%
Today’s Change
44.35
Today|||52-Week Range
94.88
+32.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$4.0B

Company Description

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-service segments. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium.

Contact Information

Galapagos NV
Industriepark Mechelen Noord
Mechelen Brussels Region 2800
P:(321) 534-2900
Investor Relations:

Employees

Shareholders

Other institutional8.42%
Mutual fund holders13.20%
Individual stakeholders--

Top Executives

Onno van de StolpeChief Executive Officer & Executive Director
Bart FiliusChief Financial Officer
Piet WigerinckChief Scientific Officer
Walid Abi-SaabChief Medical Officer
Andre HoekemaSenior Vice President-Corporate Development